Preview: Gene editing

From genetic correction to clinical impact

Gene editing is creating new opportunities to treat disease by making precise changes to DNA. From
CRISPR-Cas systems to base and prime editing, the field brings together advances in molecular engineering, delivery technologies and cell therapy. Turning these tools into treatments requires solutions to complex challenges: reaching the right tissues, minimizing unintended edits, achieving durable effects and developing scalable manufacturing processes.

Present your expertise

Drug developers, delivery specialists, technology providers, CDMOs, CROs, equipment suppliers and analytical service providers will have the opportunity to present their latest products, processes and innovations in this special feature. European Biotechnology Magazine reaches decision-makers throughout the European life sciences sector and, through our official partner SLAS, in the USA. Showcase your expertise to potential customers and partners working across gene editing research, development, manufacturing and clinical delivery. 

Examples of topics

CRISPR-Cas systems, base editing, prime editing, gene insertion, in vivo and ex vivo editing, gene-edited cell therapies, rare genetic diseases, hematology, oncology, liver and muscle targeting, viral and nonviral delivery, lipid nanoparticles, guide RNA design, nuclease engineering, off-target analysis, genomic integrity, functional screening, process development, GMP manufacturing, potency assays, clinical trial design, long-term follow-up, regulatory strategy and intellectual property.

Interested in advertising with us? We’re happy to advise you!

Contact Marketing:
Oliver Schnell
Tel.: +49-30-264921-45
oliver.schnell@knowb.io

Andreas Macht
Tel.: +49-30-264921-54
andreas.macht@knowb.io